Skip to content

National Congenital Heart Disease Audit

National Congenital Heart Disease Audit

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02303535
Enrollment
120000
Registered
2014-12-01
Start date
2000-04-30
Completion date
2017-03-31
Last updated
2016-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease (CHD)

Keywords

Congenital heart disease, European Paediatric Cardiac Code Short List, Specific Procedure Definitions, OPCS, paediatric, pediatric

Brief summary

The National Institute of Cardiovascular Outcomes Research (NICOR) collects data and produces analysis to enable hospitals and healthcare improvement bodies to monitor and improve the quality of care and outcomes of cardiovascular patients. The Congenital Heart Disease audit collects data on all cardiac surgery and therapeutic cardiac catheterisations procedures used to treat patients with congenital and acquired heart disease. For acquired heart disease, the audit covers all arrhythmias & cardiomyopathies in patients less than 16 years old only. For congenital heart disease, the audit collects data on both children and adult patients. The audit covers all specialist centers in the UK and Republic of Ireland. The project aims to improve the quality of care for children and adults with congenital heart disease by providing national comparative analysis of procedure specific activity and outcomes of cardiac surgery and therapeutic cardiac catheterisation procedures. The audit also provides quality indicators for the antenatal detection of major congenital heart disease. The current dataset is available from here: http://www.ucl.ac.uk/nicor/audits/congenital/datasets

Detailed description

The Congenital Heart Disease audit collects data on all cardiac surgery and therapeutic cardiac catheterisations procedures used to treat patients with congenital and acquired heart disease Data collection: Hospitals use Patient Administration Systems and manual data entry by cardiac database managers to submit data to NICOR. Data are either assimilated locally using third party commercial software and imported as a .csv file, or entered directly onto the NICOR database. Data quality: NICOR provide tools that communicate possible errors to centres submitting data. A data submitting schedule has been agreed with the centres, data is submitted and a validation report is returned each quarter. Centres are responsible for updating errors in the records. An import log highlights missing and invalid data as well as records that failed to import due to data quality or compatibility issues. In addition, data is validated by on site visits with a NICOR representative. Data linkage: Data is annually linked with Office fot National Statistics (ONS) life status and Hospital Episodes Statistics (HES) admission data to verify case ascertainment and to track long term outcome measures. Information governance: NICOR has Section 251 approval and data protection registration. An organisation-wide standard operating procedure is in place for Information Security Incident Management. University College London has a robust information governance framework, to which NICOR adheres.

Interventions

PROCEDURECardiac Surgery

All patients with congential and acquired heart disease treated by cardiac surgery procedures.

PROCEDURETherapeutic cardiac catheterisations procedures

All patients with congential and acquired heart disease treated by therapeutic cardiac catheterisations procedures .

Sponsors

Society for Cardiothoracic Surgery in Great Britain & Ireland
CollaboratorUNKNOWN
British Congenital Cardiac Association
CollaboratorUNKNOWN
University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patient, judged by multidisciplinary team meeting as unsuitable for the procedure

Exclusion criteria

Patient, judged by multidisciplinary team meeting, as unsuitable for the procedure

Design outcomes

Primary

MeasureTime frameDescription
30 day survival rates30 day survival from operation dateThe analysis shows the national survival rates at 30 days for each procedure and the national survival rates for individual procedures by age.

Secondary

MeasureTime frameDescription
1 year survival rates1 year survival rates after the date of the procedureAnalysis include 1-year outcome but a death would not appear in the table until a full year has passed for the whole cohort of patients within that year. For example, the audit collection period is based on financial year of April 1st to March 31st. A patient that died in April would be reported within the same period as one that died 11 months later in March.

Countries

United Kingdom

Contacts

Primary ContactJames CHAL, MHlthMgmnt
nicor-ics@ucl.ac.uk0203 549 5621

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026